Stocktoria
AVANOS MEDICAL, INC. AVNS
NYSE · XNYS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2014-10-21
AVANOS MEDICAL, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $701.2M | $687.8M | $673.3M | $684.1M | $587.0M |
| Gross profit | $353.9M | $381.3M | $379.7M | $394.2M | $299.2M |
| R&D expense | $23.3M | $26.2M | $27.2M | $29.2M | $30.6M |
| SG&A expense | $315.6M | $318.5M | $335.0M | $326.5M | $285.3M |
| Operating income | -$61.6M | -$396.2M | $4.2M | $35.5M | -$39.0M |
| Interest expense | — | — | $15.0M | $10.0M | $3.3M |
| Income tax | $6.7M | -$17.0M | $2.0M | $5.2M | -$11.2M |
| Net income | -$72.9M | -$392.1M | -$61.8M | $50.5M | $6.3M |
| EPS (diluted) | $-1.57 | $-8.53 | $-1.32 | $1.07 | $0.13 |
| Operating cash flow | $74.7M | $100.7M | $32.4M | $90.9M | $87.3M |
| Cash & equivalents | $89.8M | $107.7M | $87.7M | $127.7M | $118.5M |
| Inventory | $148.0M | $138.8M | $163.2M | $132.3M | $159.3M |
| Total assets | $1.1B | $1.2B | $1.7B | $1.8B | $1.6B |
| Total liabilities | $295.5M | $325.7M | $456.1M | $495.7M | $333.0M |
| Shareholders' equity | $778.2M | $828.5M | $1.2B | $1.3B | $1.3B |
Source: SEC EDGAR filings · CIK 0001606498 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.